Characteristic | Value |
---|---|
Gender, male | 12 |
Gender, female | 11 |
Gender, unknown | 8 |
Age (range), years | 22–70 |
Androgen/estrogen replacement therapy | 4 |
Macroadenoma | 15 |
Microadenoma | 3 |
Tumor size not reported | 13 |
Time to secondary resistance (range), years | 0.8–15 |
Malignant prolactinomas | 10 |